PMID: 1677698Aug 10, 1991Paper

Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters

Lancet
D G MakiC J Alvarado

Abstract

More than 90% of all intravascular device-related septicaemias are due to central venous or arterial catheters. To assess the efficacy of cutaneous antisepsis to prevent catheter-associated infection, we prospectively studied three antiseptics for disinfection of patients' central venous and arterial catheter insertion sites in a surgical intensive care unit. 668 catheters were randomised to 10% povidone-iodine, 70% alcohol, or 2% aqueous chlorhexidine disinfection of the site before insertion and for site care every other day thereafter. Chlorhexidine was associated with the lowest incidence of local catheter-related infection (2.3 per 100 catheters vs 7.1 and 9.3 for alcohol and povidone-iodine, respectively, p = 0.02) and catheter-related bacteraemia (0.5 vs 2.3 and 2.6). Of the 14 infusion-related bacteraemias (4 due to contaminated infusate or catheter hub, 10 due to infected catheters), 1 was in the chlorhexidine group and 13 were in the other two groups (odds ratio 0.16, p = 0.04). We conclude that use of 2% chlorhexidine, rather than 10% povidone-iodine or 70% alcohol, for cutaneous disinfection before insertion of an intravascular device and for post-insertion site care can substantially reduce the incidence of device-...Continue Reading

References

Jun 9, 1977·The New England Journal of Medicine·D G MakiH W Sarafin
Feb 1, 1979·The Journal of Hygiene·H A LillyM D Wilkins
Apr 1, 1988·The Journal of Hospital Infection·G A AyliffeH A Lilly
Jun 1, 1988·Antimicrobial Agents and Chemotherapy·J FreneyJ Fleurette
Apr 1, 1985·European Journal of Obstetrics, Gynecology, and Reproductive Biology·K K ChristensenG Kahlmeter
Jan 1, 1974·The British Journal of Surgery·E J Lowbury, H A Lilly
Dec 1, 1980·The British Journal of Surgery·L SmallmanJ Alexander-Williams

❮ Previous
Next ❯

Citations

Apr 28, 2004·Archives of Internal Medicine·Barbara W Trautner, Rabih O Darouiche
Jan 15, 2000·Journal of Biomedical Materials Research·W K LokeC K Sum
Mar 21, 1997·Pediatric Surgery International·M A HollyoakJ F Leditschke
Nov 1, 1994·Intensive Care Medicine·A F Widmer
Feb 1, 1995·Intensive Care Medicine·C R ReedB A Phelan
Feb 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S E Tebbs, T S Elliott
Jul 1, 1997·Indian Journal of Pediatrics·V BhandariJ Rowe
Jan 20, 2007·Intensive Care Medicine·M Angeles García-TeresaUNKNOWN Spanish Central Venous Catheter Pediatric Study Group
Jul 16, 2008·Intensive Care Medicine·Jose Garnacho-MonteroCarlos Ortiz-Leyba
Dec 8, 2010·Cardiovascular and Interventional Radiology·P Y MarcyA Figl
Sep 29, 1999·Cardiovascular and Interventional Radiology·J Namyslowski, N H Patel
Jul 17, 2008·Annals of Hematology·Hans-Heinrich WolfUNKNOWN Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Sep 21, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Fabio PaglialongaNicola Principi
Apr 9, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Deepa H ChandElaine S Kamil
Jul 3, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Caitlin E Carter, Nadine M Benador
Sep 30, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Geng TianHaidan Xu
Jun 5, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V CecinatiS Esposito
Nov 28, 2001·Current Infectious Disease Reports·Nasia SafdarDennis G. Maki
Oct 24, 2013·Current Infectious Disease Reports·C L AbadN Safdar
Nov 30, 2000·Current Infectious Disease Reports·D P Calfee, B M Farr
Aug 1, 1992·Diagnostic Microbiology and Infectious Disease·N Chin, H C Neu
Jul 1, 1995·FEMS Immunology and Medical Microbiology·B Rozalska, A Ljungh
Feb 6, 2004·Best Practice & Research. Clinical Anaesthesiology·Bernard CanaudJean-Jacques Béraud
Oct 26, 2010·Critical Care Clinics·Omar Rahman, Laurel Willis
Dec 5, 2002·AORN Journal·Cynthia G Segal, Jacqueline J Anderson
Dec 31, 1998·The American Journal of Medicine·S Saint, M A Matthay
May 23, 2003·Gastroenterology·Lyn Howard, Christopher Ashley
Aug 16, 2000·Pediatric Clinics of North America·G L Darmstadt, J G Dinulos
Mar 25, 1995·Lancet·S E TebbsT S Elliott
Jun 12, 1999·Annals of the Royal College of Surgeons of England·C D SuttonM H Lewis
Jul 3, 1998·Gastroenterology Clinics of North America·L Howard, N Hassan
Sep 26, 2001·Infectious Disease Clinics of North America·A H Cheung, L M Wong
Feb 1, 1997·Applied Nursing Research : ANR·L L Larsen, N E Thurston
Mar 1, 1996·Nutrition·K A Adal, B M Farr
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H C Traunecker, B J Morland
Feb 13, 2003·Journal of Vascular and Interventional Radiology : JVIR·Donald L Miller, Naomi P O'Grady
Jun 1, 2009·Seminars in Interventional Radiology·Tracie A Wilcox

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.